Position in JNJ
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$6,948,940
+$1,480,494 QoQ
Shares Held
28,428
+7.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.51%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Larson Financial Group LLC holds $47,576,049 across 18 Drug Manufacturers - General names. JNJ ranks #4 (14.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
17,014 | $15,648,966 | |
| 2 | ABBV |
AbbVie Inc.
|
35,942 | $7,817,025 | |
| 3 | MRK |
Merck & Co., Inc.
|
59,707 | $7,182,155 | |
| 4 | JNJ |
Johnson & Johnson
This page
|
28,428 | $6,948,940 | |
| 5 | PFE |
Pfizer Inc
|
109,981 | $3,088,266 | |
| 6 | AMGN |
Amgen Inc
|
6,334 | $2,228,617 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
33,017 | $2,002,481 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
12,065 | $1,681,499 |
All Filings in JNJ
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,948,940 | 28,428 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $5,468,446 | 26,424 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $5,296,336 | 28,564 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $4,069,107 | 26,639 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $4,103,047 | 24,741 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $2,743,730 | 18,972 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $3,273,287 | 20,198 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $2,377,438 | 16,266 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $4,997,854 | 31,594 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $3,141,853 | 20,045 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $2,997,564 | 19,246 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $3,222,343 | 19,468 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $2,961,740 | 19,108 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $5,663,752 | 32,062 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $4,777,626 | 29,246 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $1,379,607 | 7,772 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $1,000,286 | 5,644 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $965,690 | 5,645 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $722,712 | 4,475 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $698,003 | 4,237 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $702,596 | 4,275 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $627,631 | 3,988 | Shares | Sole | 2021-01-14 | |
| 2020-09-30 | $561,724 | 3,773 | Shares | Sole | 2020-10-08 | |
| 2020-06-30 | $503,314 | 3,579 | Shares | Sole | 2020-07-10 | |
| 2020-03-31 | $451,480 | 3,443 | Shares | Sole | 2020-04-09 | |
| No filing history on record for this holder in this stock. | ||||||